---
title: "Bluejay Diagnostics Soars 51% After Intraday Dip in Heavy Trading"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294998839.md"
description: "Bluejay Diagnostics (BJDX) jumped 51% in regular trading to $1.51 after an intraday flash dip, trading over 79 million shares."
datetime: "2026-08-05T18:01:56.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294998839.md)
  - [en](https://longbridge.com/en/news/294998839.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294998839.md)
generator: "portal-rs"
---

# Bluejay Diagnostics Soars 51% After Intraday Dip in Heavy Trading

Bluejay Diagnostics(BJDX.US) 盘中触发 5 分钟内急跌超 5% 信号，当日累计涨超 51%，现报**1.51**美元。

消息面上，Bluejay Diagnostics 自盘前起持续走强，此前已有报道指出该股在盘前交易中上涨约 40%，开盘后延续升势，盘中成交量达**7922.97 万**股。此外，多份行业异动报道将其列为周三医疗保健板块活跃标的之一。

### Related Stocks

- [BJDX.US](https://longbridge.com/en/quote/BJDX.US.md)

## Related News & Research

- [Bluejay Diagnostics partners with Lovell Government Services to target US federal healthcare market](https://longbridge.com/en/news/298302497.md)
- [Bluejay Diagnostics says SYMON-II pivotal study completes enrollment of 750 patients for Symphony IL-6 test](https://longbridge.com/en/news/295778817.md)
- [Bluejay Diagnostics announces SYMON-II sepsis study enrollment completion](https://longbridge.com/en/news/293326776.md)
- [Bluejay Diagnostics Completes Enrollment in SYMON-II Sepsis Study](https://longbridge.com/en/news/293531257.md)
- [Bluejay Diagnostics Announces up to $23.6 Million Private Placement Priced At-the-Market Under Nasdaq Rules | BJDX Stock News](https://longbridge.com/en/news/288455979.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**